홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 파머슈티컬 > 암치료 > Issues; Trends and Prevalence in the European Cancer Therapy Market- Non Pharmaceutical
카테고리
파머슈티컬 (4931)
감염질환 (349)
골질환 치료 (38)
당뇨병 (194)
백신 (181)
비만치료/다이어트 (44)
비처방 의약품 (152)
수의학 (17)
신경질환 (174)
신약개발 (1529)
암치료 (941)
약물전달 (185)
의약품 규제환경 (127)
정신질환 (86)
제네릭 의약품 (128)
제약회사분석 (523)
처방약 (165)
시장보고서

Issues; Trends and Prevalence in the European Cancer Therapy Market- Non Pharmaceutical

리서치사 Frost & Sullivan
발행일 2008년 10월 상품코드 75567
페이지 정보 160 Pages
가격
US $ 6,500 ￦ 7,744,700 Web Access (Regional License)
US $ 7,000 ￦ 8,340,500 Hard Copy & Web Access (Regional License)


영문목차

Abstract

This research service examines the Issues, trends and prevalence in the European cancer therapy market in terms of the challenges faced by market participants, drivers, and restraints in the industry, the competitive structure in the major markets as well as the upcoming technologies.

Table of Contents

1. EXECUTIVE SUMMARY

  • Summary of Major Findings
    • 1. Executive Summary

2. RESEARCH SCOPE AND METHODOLOGY

  • Scope and Methodology
    • 1. Scope and Methodology

3. INTRODUCTION

  • Introduction
    • 1. Research Study Overview
    • 2. Cancer

4. TYPES OF CANCER

  • Introduction
    • 1. Introduction to Types of Cancers
  • Breast Cancer
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Lung Cancer
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Colon Cancer
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Prostate Cancer
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Leukemia
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Lymphoma
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence
  • Uterine Cancer
    • 1. Introduction
    • 2. Staging
    • 3. Treatment Modality
    • 4. Issues and Trends
    • 5. Prevalence

5. MARKET OUTLOOK

  • Introduction
    • 1. Radiotherapy Devices
  • Industry Challenges
    • 1. Challenges in the European Market
  • Drivers and Restraints
    • 1. Drivers
    • 2. Restraints
  • Key Market Participants and Products Available
    • 1. Key Market Participants
    • 2. Key Products
  • Country Profile
    • 1. Germany
    • 2. France
    • 3. Italy
    • 4. Spain
    • 5. United Kingdom
    • 6. Benelux
    • 7. Scandinavia
  • Radiotherapy Resources
    • 1. Radiotherapy Resources in Europe
  • Treatment Distribution
    • 1. Treatment Distribution in Europe

6. THINKING OUTSIDE THE BOX

  • Competitive Structure and Opportunities
    • 1. Competitive Structure
    • 2. Opportunities
  • Future Outlook
    • 1. A Future Outlook for the European Industry
  • Conclusion
    • 1. Radiotherapy Devices- Conclusion

7. DECISION SUPPORT DATABASE

  • Database
    • 1. Number of Hospitals- Western Europe
    • 2. Private Healthcare Expenditure
    • 3. Government Healthcare Expenditure
    • 4. Population Aged 65 and above
    • 5. Per Capita Healthcare Expenditure
Back to Top